cytarabine and xav939

cytarabine has been researched along with xav939 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, Z; Gong, Y; Kim, SB; Lee, JS; Mallampati, S; Sun, B; Sun, X; Yang, Y; Zhang, J	1

Other Studies

1 other study(ies) available for cytarabine and xav939

Article	Year
Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target. Cancer letters, 2013, Jun-01, Volume: 333, Issue:1 Topics: Animals; Apoptosis; beta Catenin; Cell Cycle; Cytarabine; Gene Expression Regulation, Leukemic; Heterocyclic Compounds, 3-Ring; Humans; Mesenchymal Stem Cells; Mice; Mice, SCID; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Wnt Signaling Pathway	2013

Article

Year

Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target.

Cancer letters, 2013, Jun-01, Volume: 333, Issue:1

Topics: Animals; Apoptosis; beta Catenin; Cell Cycle; Cytarabine; Gene Expression Regulation, Leukemic; Heterocyclic Compounds, 3-Ring; Humans; Mesenchymal Stem Cells; Mice; Mice, SCID; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Wnt Signaling Pathway

2013